Investments in Unconsolidated Entities (Details 7) - USD ($) $ in Thousands	Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021
Condensed Balance Sheets:
Total cash, cash equivalents, and restricted cash shown on the Condensed Consolidated Statements of Cash Flows	$ 838,883	$ 1,398,550	$ 724,311	$ 1,684,412
Inventory	9,099,485	8,733,326
Other	102,732	135,604
Total assets	11,984,883	12,288,714
Stockholders' Equity Attributable to Noncontrolling Interest	15,647	15,752
Total liabilities and stockholders' equity	11,984,883	12,288,714
Investments in unconsolidated entities	908,949	852,314
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity	(17,500)	(18,500)
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Condensed Balance Sheets:
Total cash, cash equivalents, and restricted cash shown on the Condensed Consolidated Statements of Cash Flows	245,014	254,884
Inventory	1,311,563	1,256,215
Loans Receivable, Net	48,342	48,217
Rental Properties	1,795,600	1,702,690
Rental properties under development	1,498,838	1,413,607
Other	361,197	305,250
Total assets	5,260,554	4,980,863
Debt, net of deferred financing costs	2,421,511	2,248,754
Accrued Liabilities and Other Liabilities	393,811	399,818
Members' Equity	2,445,232	2,332,291
Total liabilities and stockholders' equity	5,260,554	4,980,863
Investments in unconsolidated entities	$ 908,949	$ 852,314